US-based biotechnology company Therini Bio has reported positive results from a Phase Ia trial of THN391, a potential ...

Osteoarthritis (OA), a common degenerative joint disease that affects millions of people worldwide, particularly targets the ...

In preclinical models of PD, GT-02287 restored GCase enzymatic function, reduced ER stress, lysosomal and mitochondrial pathology, aggregated α-synuclein, neuroinflammation and neuronal death, as well ...

SIRT2, an enzyme previously overlooked in astrocytic GABA production, may be crucial for distinguishing the specific effects ...

A pioneering study has unveiled a revolutionary technique that enhances stem cell therapy for neurodegenerative diseases by ...

A harmful form of the tau protein, which builds up in Alzheimer's disease and similar brain disorders, can directly damage ...

The three-year limit is insufficient and outdated. In France, a study on screen use among children raises the alarm, urging ...

Whether you are a person about town or a worm in a dish, life can throw all kinds of circumstances your way. What you need is ...

The U.S. Food and Drug Administration notified consumers of a recall for a “healthy aging” supplement.The recall, initiated due to an undeclared allergen, has been officially labeled a Class 1 recall, ...

A harmful form of the tau protein, which builds up in Alzheimer's disease and similar brain disorders, can directly damage blood vessels in the brain ...

The company’s exhibitions will be focused in the areas of its pipeline, proprietary capsid engineering, and manufacturing.

THERANEXUS - THERANEXUS PUBLISHES ITS 2024 FULL-YEAR RESULTS, PRESENTS ITS PROGRESS REPORT AND CLOSES ITS EQUITY LINE ...